Back
Day Range
$70.68
$73.61
52-Week Range
$23.95
$86.74
Volume
2,928,321
50D / 200D Avg
$79.69
/
$64.60
Prev Close
$69.68
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -31.5 | 0.3 |
| P/B | 24.6 | 3.0 |
| ROE % | -70.7 | 3.7 |
| Net Margin % | -40.4 | 3.8 |
| Rev Growth 5Y % | 3.9 | 10.0 |
| D/E | 5.4 | 0.2 |
Analyst Price Target
Hold
$91.33
+25.6%
Low: $65.00
High: $103.00
Forward EPS
-$3.82
Est. Revenue
827.95M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$6.11
$4.73 – $7.44
|
3.50B | 4 |
| FY2029 |
$3.26
$2.52 – $3.97
|
2.70B | 4 |
| FY2028 |
$0.46
-$11.68 – $10.51
|
1.87B | 10 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | -$1.24 | -$1.14 | +7.8% |
| 2025-10-29 | -$1.15 | -$0.61 | +47.0% |
| 2025-07-30 | $0.27 | $0.86 | +218.5% |
| 2025-04-30 | -$1.11 | -$0.75 | +32.4% |
| 2025-02-19 | -$1.09 | -$0.66 | +39.4% |
| 2024-11-06 | -$1.16 | -$0.95 | +18.1% |
| 2024-08-01 | -$0.92 | -$0.45 | +51.1% |
| 2024-05-07 | -$1.05 | -$0.98 | +6.4% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 3.89% annually over 5 years — modest growth
Debt/Equity of 5.35 — high leverage
Negative free cash flow of -320.03M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 29.98%
Capital efficient — spends only 5.45% of revenue on capex
Growth
Revenue Growth (5Y)
3.89%
Revenue (1Y)33.87%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-70.72%
ROIC-9.23%
Net Margin-40.36%
Op. Margin-40.47%
Safety
Debt / Equity
5.35
Current Ratio3.83
Interest Coverage-5.23
Valuation
P/E Ratio
-31.52
Forward P/EN/A
P/B Ratio24.55
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 33.87% | Revenue Growth (3Y) | 9.48% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3.89% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 944.00M | Net Income (TTM) | -381.00M |
| ROE | -70.72% | ROA | -10.81% |
| Gross Margin | 98.31% | Operating Margin | -40.47% |
| Net Margin | -40.36% | Free Cash Flow (TTM) | -320.03M |
| ROIC | -9.23% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 5.35 | Current Ratio | 3.83 |
| Interest Coverage | -5.23 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -31.52 | Forward P/E | N/A |
| P/B Ratio | 24.55 | P/S Ratio | 12.72 |
| PEG Ratio | 1.53 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 14.50 | Fwd Earnings Yield | N/A |
| FCF Yield | -2.66% | ||
| Market Cap | 12.01B | Enterprise Value | 14.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 944.00M | 705.14M | 787.65M | 587.37M | 810.46M |
| Net Income | -381.00M | -453.90M | -366.29M | -269.72M | -28.60M |
| EPS (Diluted) | -2.38 | -3.04 | -2.56 | -1.90 | -0.20 |
| Gross Profit | 928.00M | 693.92M | 778.51M | 573.25M | 799.61M |
| Operating Income | -382.00M | -475.08M | -353.73M | -410.19M | -30.19M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.52B | 3.00B | 2.99B | 2.53B | 2.61B |
| Total Liabilities | 3.03B | 2.42B | 2.60B | 1.96B | 1.84B |
| Shareholders' Equity | 489.09M | 588.35M | 386.69M | 572.89M | 771.74M |
| Total Debt | 2.61B | 1.42B | 1.45B | 1.37B | 1.25B |
| Cash & Equivalents | 372.26M | 242.08M | 399.27M | 276.47M | 869.19M |
| Current Assets | 2.99B | 2.62B | 2.64B | 2.20B | 2.35B |
| Current Liabilities | 781.57M | 309.32M | 448.09M | 311.56M | 240.55M |